|
|
||||||||




A series of lepidines (6-methoxy-4-methyl-8-aminoquinoline derivatives) was studied in a hamster-Leishmania donovani model. Members of this class were found to have activity many-fold that of the standard, meglumine antimoniate (Glucantime®). One of them, 8-(6-diethylamino-hexylamino)-6-methoxy-4-methylquinoline, designated WR 6026, when given orally was over 700 times as effective as the standard antimonial drug.
Accepted for publication March 11, 1978.
* The experiments reported herein were conducted according to the principles set forth in the Guide for the Care and Use of Laboratory Animals, Institute of Laboratory Animal Resources, National Research Council, DHEW Publ. No. 74-23.
Present address: School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20014.
Present address: Animal Assessment Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland 21701.
Department of Parasitology, College of Veterinary Medicine, University of Georgia.
|| Department of Pathology, College of Veterinary Medicine, University of Georgia.
This article has been cited by other articles:
![]() |
N. P. D. Nanayakkara, A. L. Ager Jr., M. S. Bartlett, V. Yardley, S. L. Croft, I. A. Khan, J. D. McChesney, and L. A. Walker Antiparasitic Activities and Toxicities of Individual Enantiomers of the 8-Aminoquinoline 8-[(4-Amino-1-Methylbutyl)Amino]-6-Methoxy-4-Methyl-5-[3,4-Dichlorophenoxy]Quinoline Succinate Antimicrob. Agents Chemother., June 1, 2008; 52(6): 2130 - 2137. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Croft, S. Sundar, and A. H. Fairlamb Drug Resistance in Leishmaniasis Clin. Microbiol. Rev., January 1, 2006; 19(1): 111 - 126. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |